Free Trial

SEP Acquisition (SEPA) Competitors

$9.30
+0.26 (+2.88%)
(As of 05/31/2024 08:51 PM ET)

SEPA vs. OXUS, MAQC, SWSS, FAZE, TPBA, TLSI, DCTH, NPCE, PROF, and DRTS

Should you be buying SEP Acquisition stock or one of its competitors? The main competitors of SEP Acquisition include Oxus Acquisition (OXUS), Maquia Capital Acquisition (MAQC), Clean Energy Special Situations (SWSS), FaZe (FAZE), TPB Acquisition Co. I (TPBA), TriSalus Life Sciences (TLSI), Delcath Systems (DCTH), NeuroPace (NPCE), Profound Medical (PROF), and Alpha Tau Medical (DRTS).

SEP Acquisition vs.

SEP Acquisition (NASDAQ:SEPA) and Oxus Acquisition (NASDAQ:OXUS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, community ranking, dividends, profitability and media sentiment.

SEP Acquisition has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500. Comparatively, Oxus Acquisition has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500.

3.7% of SEP Acquisition shares are held by institutional investors. Comparatively, 28.3% of Oxus Acquisition shares are held by institutional investors. 20.0% of SEP Acquisition shares are held by insiders. Comparatively, 65.7% of Oxus Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
SEP AcquisitionN/A N/A -38.32%
Oxus Acquisition N/A N/A -1.68%

SEP Acquisition and Oxus Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
SEP AcquisitionN/AN/A
Oxus AcquisitionN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SEP AcquisitionN/AN/A-$2.36MN/AN/A
Oxus AcquisitionN/AN/A-$300K-$0.21-43.29

In the previous week, SEP Acquisition had 4 more articles in the media than Oxus Acquisition. MarketBeat recorded 4 mentions for SEP Acquisition and 0 mentions for Oxus Acquisition. SEP Acquisition's average media sentiment score of 1.44 beat Oxus Acquisition's score of 0.00 indicating that SEP Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
SEP Acquisition Positive
Oxus Acquisition Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SEP Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Oxus Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Oxus Acquisition beats SEP Acquisition on 4 of the 7 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SEPA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SEPA vs. The Competition

MetricSEP AcquisitionSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$54.08M$3.90B$5.18B$7.99B
Dividend YieldN/A1.80%2.77%4.00%
P/E RatioN/A16.07139.9218.59
Price / SalesN/A66.572,393.9477.33
Price / CashN/A48.0435.7131.55
Price / Book-8.025.075.554.59
Net Income-$2.36M$4.50M$106.21M$213.90M
7 Day Performance9.80%1.27%1.15%0.87%
1 Month Performance-7.00%-1.49%0.65%1.82%
1 Year Performance-6.53%-17.83%2.66%5.90%

SEP Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OXUS
Oxus Acquisition
0 of 5 stars
$7.95
+8.2%
N/A-14.7%$52.17MN/A-37.862,021Gap Down
High Trading Volume
MAQC
Maquia Capital Acquisition
0 of 5 stars
$11.03
+0.1%
N/A+1.7%$68.17MN/A0.004
SWSS
Clean Energy Special Situations
0 of 5 stars
$11.03
+4.3%
N/A+11.4%$69.38MN/A0.002,021Positive News
FAZE
FaZe
0 of 5 stars
$0.18
flat
N/A-65.9%$14.14M$70.02M0.00108
TPBA
TPB Acquisition Co. I
0 of 5 stars
$5.81
-1.2%
N/A-0.3%$134.03MN/A0.002,021
TLSI
TriSalus Life Sciences
2.7146 of 5 stars
$7.82
+3.4%
$16.00
+104.6%
N/A$212.39M$18.51M0.00112Positive News
Gap Up
DCTH
Delcath Systems
3.1216 of 5 stars
$7.48
-3.9%
$20.20
+170.1%
-3.3%$207.87M$2.07M-2.8276Positive News
NPCE
NeuroPace
3.0203 of 5 stars
$6.85
-9.0%
$15.67
+128.7%
+68.1%$197.07M$65.42M-5.76171Positive News
PROF
Profound Medical
2.4162 of 5 stars
$7.40
+1.2%
$14.58
+97.1%
-45.0%$180.78M$7.20M-5.74131Positive News
DRTS
Alpha Tau Medical
2.9949 of 5 stars
$2.47
-2.4%
$12.00
+385.8%
-45.4%$172.09MN/A-6.02121Short Interest ↓
Gap Up

Related Companies and Tools

This page (NASDAQ:SEPA) was last updated on 6/3/2024 by MarketBeat.com Staff

From Our Partners